VOP-visi odontologiniai produktai, UAB - financials and debts

Company age: 17 y. 1 mo.

Update

VOP-visi odontologiniai produktai - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 157,461 142,696 256,311 256,113 275,922 275,449 334,435 484,439
Profit before tax 4,044 4,555 41,973 7,119 11,099 7,034 2,922 2,818
Net profit 3,805 4,316 39,877 6,742 10,985 6,677 2,329 2,284
Equity 40,260 44,576 84,453 91,195 77,180 78,858 76,187 73,471
Liabilities 54,780 59,832 62,233 69,261 78,374 125,621 131,010 116,736
Non-current assets 13,367 10,144 8,215 6,516 12,634 36,344 27,035 20,859
Current assets 81,673 94,128 138,471 153,878 142,790 167,407 179,304 168,384
Total assets 95,040 104,272 146,686 160,394 155,424 203,751 206,339 189,243
Taxes paid
STI taxes - - - - - 38,056 57,964 69,437
Financial indicators
Revenue change y/y -12.1% -9.4% +79.6% -0.1% +7.7% -0.2% +21.4% +44.9%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 4.0% 4.1% 27.2% 4.2% 7.1% 3.3% 1.1% 1.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 9.5% 9.7% 47.2% 7.4% 14.2% 8.5% 3.1% 3.1%
Profit margin Net profit margin. Shows the overall profitability of the company. 2.4% 3.0% 15.6% 2.6% 4.0% 2.4% 0.7% 0.5%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 2.6% 3.2% 16.4% 2.8% 4.0% 2.6% 0.9% 0.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.4 1.3 0.7 0.8 1.0 1.6 1.7 1.6
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 157,461 142,696 219,689 128,057 137,961 137,725 133,774 207,620

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

VOP-visi odontologiniai produktai - Social security debts

From To Debt, €
2025-04-30 2025-04-30 0.03
2025-04-16 2025-04-22 0.03
2025-03-18 2025-03-23 0.23
2025-02-18 2025-03-13 0.23
2025-01-16 2025-02-13 0.21
2025-01-02 2025-01-14 0.21
2024-12-22 2024-12-31 0.21
2024-12-17 2024-12-20 0.21
2024-11-18 2024-12-12 0.21
2024-10-16 2024-11-13 0.21
2024-09-17 2024-10-13 0.21
2024-08-19 2024-09-15 0.21
2024-07-16 2024-08-13 0.21
2024-06-18 2024-07-11 0.21
2024-05-16 2024-06-11 0.21
2024-04-16 2024-05-12 0.21
2024-03-18 2024-04-11 0.21
2024-02-19 2024-03-12 0.21
2024-01-23 2024-02-14 0.21
2023-07-26 2023-07-27 373.77
2023-07-24 2023-07-25 373.91
2023-07-21 2023-07-23 373.77
2023-07-20 2023-07-20 374.42
2023-07-18 2023-07-19 507.36
2023-06-16 2023-07-17 0.65
2023-05-02 2023-06-12 0.65
2023-04-26 2023-04-28 0.65
2023-04-18 2023-04-23 13.62
2023-03-20 2023-04-13 13.62
2023-03-16 2023-03-19 375.31
2023-02-17 2023-03-15 1.54
2023-01-24 2023-02-01 1.54
2023-01-17 2023-01-23 1.43
2022-11-21 2023-01-15 1.83
2022-11-17 2022-11-18 1.83
2022-10-28 2022-11-14 1.43
2022-10-18 2022-10-27 1.10
2022-09-16 2022-10-12 1.10
2022-08-23 2022-09-14 1.10
2022-07-25 2022-08-15 1.10
2022-06-16 2022-07-24 0.67
2022-05-17 2022-06-14 0.67
2022-04-28 2022-05-09 0.67
2022-03-16 2022-04-27 0.47
2022-01-31 2022-03-13 0.47
2022-01-18 2022-01-30 0.38
2021-12-16 2022-01-16 0.38
2021-11-05 2021-12-14 0.38
2021-10-18 2021-11-04 0.27
2021-08-17 2021-10-14 0.27

VOP-visi odontologiniai produktai - VMI tax arrears

From To Overdue, €
2026-08-12 2026-08-13 37.25
2026-05-15 2026-05-18 68.24
2026-04-30 2026-05-14 0.74
2026-04-16 2026-04-26 0.44
2026-04-15 2026-04-15 67.94
2026-03-27 2026-04-14 0.44
2026-03-20 2026-03-21 168.0
2026-03-02 2026-03-02 75.67
2026-02-21 2026-02-21 74.9
2026-02-18 2026-02-20 20.9
2026-01-27 2026-02-16 0.09
2026-01-16 2026-01-26 1.09
2026-01-01 2026-01-15 0.33
2025-12-18 2025-12-29 0.33
2025-12-17 2025-12-17 67.95
2025-12-01 2025-12-16 0.45
2025-11-15 2025-11-18 52.49
2025-09-17 2025-09-17 0.16
2025-08-12 2025-08-12 15.83
2025-08-10 2025-08-11 484.67
2025-08-09 2025-08-09 551.35
2025-08-08 2025-08-08 551.72
2025-08-01 2025-08-07 16.5
2025-07-31 2025-07-31 3.0
2025-07-26 2025-07-30 0.3
2025-07-25 2025-07-25 0.32
2025-07-15 2025-07-20 68.13
2025-06-28 2025-07-14 0.63
2025-06-26 2025-06-27 0.48
2025-06-25 2025-06-25 0.63
2025-06-19 2025-06-24 0.45
2025-06-18 2025-06-18 0.3
2025-05-29 2025-06-12 0.45
2025-05-07 2025-05-13 16.3
2025-03-23 2025-03-24 0.6
2025-03-22 2025-03-22 0.78
2025-03-20 2025-03-21 224.6
2025-03-19 2025-03-19 135.0
2025-02-28 2025-02-28 98.22
2025-02-20 2025-02-25 98.22
2025-02-15 2025-02-19 0.22
2025-01-31 2025-02-14 4.9
2025-01-30 2025-01-30 4.96
2025-01-28 2025-01-29 0.03
2025-01-16 2025-01-27 0.31
2024-12-30 2025-01-15 0.28
2024-12-21 2024-12-27 0.28
2024-12-20 2024-12-20 0.3
2024-12-15 2024-12-17 74.46
2024-12-14 2024-12-14 74.49
2024-11-28 2024-12-13 6.96
2024-10-28 2024-11-25 6.72
2024-10-16 2024-10-16 141.08
2024-09-17 2024-10-15 6.08

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
VOP-visi odontologiniai produktai, UAB (code 302428038) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €484.4K, up 44.9% year on year and 75.9% over two years. Net profit was €2.3K, with a profit margin of 0.5%, indicating that profitability remained thin despite stronger sales. The 2023–2025 trend shows steady revenue expansion from €275.4K in 2023 to €334.4K in 2024 and €484.4K in 2025, while net profit declined from €6.7K to €2.3K and then remained broadly stable. At the end of 2025, total assets stood at €189.2K, equity at €73.5K and liabilities at €116.7K. The equity ratio was 38.8% and debt-to-equity 1.59, pointing to a moderate leverage position. Asset turnover reached 2.56x, while return on equity was 3.1% and return on assets 1.2%. Revenue per employee was €242.2K and profit per employee €1.1K.